Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone + Metformin vs Metformin in Nonobese PCOS
NCT05519813Phase 4Unknown
- Start
- Jan 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of pioglitazone in polycystic ovary syndrome (PCOS) (2 arms). Primary endpoint: Sex Hormone Binding Globulin at 12 weeks. Status: unknown.
02
Drugs
pioglitazone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05519813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05519813.